During the last session, NKGen Biotech Inc (NASDAQ:NKGN)’s traded shares were 0.63 million, with the beta value of the company hitting 0.52. At the end of the trading day, the stock’s price was $0.27, reflecting an intraday loss of -3.08% or -$0.01. The 52-week high for the NKGN share is $4.06, that puts it down -1403.7 from that peak though still a striking 25.93% gain since the share price plummeted to a 52-week low of $0.20. The company’s market capitalization is $9.49M, and the average intraday trading volume over the past 10 days was 2.91 million shares, and the average trade volume was 1.06 million shares over the past three months.

NKGen Biotech Inc (NASDAQ:NKGN) trade information

NKGen Biotech Inc (NKGN) registered a -3.08% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -3.08% in intraday trading to $0.27, hitting a weekly high. The stock’s 5-day price performance is -33.07%, and it has moved by -31.31% in 30 days. Based on these gigs, the overall price performance for the year is -90.49%. The short interest in NKGen Biotech Inc (NASDAQ:NKGN) is 0.43 million shares and it means that shorts have 1.14 day(s) to cover.

NKGN Dividends

NKGen Biotech Inc is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

NKGen Biotech Inc (NASDAQ:NKGN)’s Major holders

NKGen Biotech Inc insiders own 42.32% of total outstanding shares while institutional holders control 10.03%, with the float percentage being 17.39%.